The objective of this study was to investigate the association of serum UA with either FPG or 2hPG levels among Chinese adults in Qingdao, China. A population-based survey for diabetes was performed in 2006 in Qingdao. The survey included 1,490 men and 2,325 women aged 35-74 years who had data stored as required for the current data analysis. The association of mean UA with plasma glucose was tested using a linear regression model. Serum UA concentration raised with increasing FPG levels up to FPG of 7.0 mmol/l, but significantly decreased thereafter with further increase in FPG levels. The multivariate adjusted β coefficient between FPG and UA in individuals with newly diagnosed diabetes was -0.20 for men and -0.27 for women (p<0.01 for both). A declining trend for the UA concentration was also observed at 2hPG of 10 mmol/l or higher in both genders. Fasting serum UA levels was higher in the pre-diabetic population but lower in people with diabetes than in normoglycaemic people. UA may serve as a potential biomarker of deterioration in glucose metabolism, but its clinical implication need to be further studied.
Introduction
UA is the final oxidation product of purine catabolism in humans with the loss of uricase. There has been a growing interest in the association of hyperuricaemia with hyperglycemia 1-5 since this was first described in 1923. 6 Cross-sectional studies in Melanesian and Asian Indians, 3 in Israeli men, 2 in Caucasians 7 and in Chinese 8 have all shown a notably low UA level among patients with newly diagnosed diabetes. In contrast, UA was significantly elevated in people with IGT, 3 and in those with FPG up to 7.0-8.0 mmol/l in men and to 9.0mmol/l in women. [7] [8] [9] In this study, the association of UA with either FPG or 2hPG levels was investigated taking into account possible confounding factors based on the data collected in Qingdao, China in 2006.
Methods

Study population
A population-based cross-sectional study was conducted in three urban districts (Shinan, Shibei, and Sifang) and three rural counties (Jiaonan, Huangdao, and Jimo) in Qingdao, China. Five residential communities from each district and 200-250 residents living in Qingdao for at least 5 years from each community were randomly following an overnight fast for at least 10 hours. After registration, participants were interviewed by trained doctors or nurses. The questionnaire contained questions on demographic data, seafood consumption, drinking and smoking information, personal and family history of diabetes and gout, previous history of hypertension, cardiovascular disease and dyslipidaemia. Each participant was asked whether he/she had previously been diagnosed with diabetes. If the answer was 'yes', the glucose level when the diagnosis was made and the treatment of diabetes were reviewed by a doctor who confirmed the diagnosis. A participant was classified as an alcohol drinker if he/she drank beer, wine, or liquors frequently during the last 1 year. Height and weight was measured with participants wearing light clothes and without shoes. BMI was then calculated by dividing weight (kg) by height (m) squared. Waist circumference was measured at the middle of the rib cage and iliac crest, and the hip circumference at the maximal horizontal girth between the waist and thigh. Three consecutive blood pressure readings, at least 30 seconds apart, were taken from the right arm of seated subjects, and the average of the three readings was used in the current data analysis. All participants without diagnosed diabetes were examined with a standard 2-hour 75 g OGTT. Blood samples were collected from the antecubital vein into a vacuum tube containing sodium fluoride. The specimens were placed in ice-cooled containers and transported immediately to the central laboratory of Qingdao Hiser Medical Center. The assays of plasma glucose and serum lipids of the 2006 survey were determined using Olympus-AU 640 Automatic analysers in the same laboratory. FPG and 2hPG was determined by the glucose oxidase method, and fasting serum UA, creatinine, C-reactive protein, triglycerides, Apo A, Apo B, total and HDL-C with enzymatic method. A microparticle enzyme immunoassay (AxSYM, Abbott) was applied to measure serum insulin.
Subjects who reported a history of diabetes and who were under treatment with either insulin or oral anti-diabetic agents were considered to have known diabetes, regardless of their FPG levels. Participants without known diabetes were divided into glucose categories according to either FPG or 2hPG distributions. Data on history of dyslipidaemia and cardiovascular disease were based on a self-reported questionnaire. Hypertension was defined as systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg and/or being on antihypertensive therapy. Dyslipidaemia was defined as triglycerides ≥1.7 mmol/L and/or HDL-C <0.9 mmol/L (men) and <1.0 mmol/ L (women).
Statistical analysis
Data were summarised as mean (± standard error) for continuous variables and proportions for categorical variables. Fasting serum triglycerides and insulin were logarithmically transformed for all analyses and the geometric means were presented. The mean values of BMI, waist, waist to hip ratio, blood pressure, serum UA, lipids and insulin were estimated using the general linear model adjusting for age and residential area; the difference between FPG categories and known diabetes was tested using UNIANOVA. The chi-squared test was employed to estimate the difference for categorical variables. The data were further analysed for the small FPG intervals of <4.5, 4.5-5.5, 5.6-6.0, 6.1-6.9, 7.0-7.9, 8.0-9.9 and ≥10.0 mmol/l, and for the small 2hPG intervals of <4.5, 4.5-5.5, 5.6-6.0, 6.1-6.9, 7.0-7.9, 8.0-8.9, 9.0-9.9, 10.0-11.0, 11.1-13.0 and >13.0 mmol/l in subjects without previously diagnosed diabetes and gout. The general linear model was employed to test the associations between these small FPG and 2hPG intervals and serum UA separately for men and women, adjusting for age, residential area, BMI, log-triglycerides, creatinine, C-reactive protein and a history of hypertension and cardiovascular disease before the survey. Systolic blood pressure and diastolic blood pressure were added into the model separately. A p-value of <0.05 (two-tailed) was considered to be statistically significance. All analyses were performed using SPSS for Windows, version 15.0.
Results
Individuals with IFG or newly diagnosed diabetes (FPG of >7.0 mmol/l) were older, more obese, and more likely to have higher triglycerides and lower HDL-C than those with FPG of <6.1 mmol/l, in either men or women (p<0.05; Table 1 ). Individuals with IFG had the highest serum UA levels, and those with previously diagnosed diabetes had the lowest UA levels in both genders. Fasting insulin were notably higher for IFG and undiagnosed diabetes than for diagnosed diabetes in women but not in men. Both undiagnosed and diagnosed diabetes had higher C-reactive protein than subjects with IFG. Positive family history of diabetes or personal history of hypertension, cardiovascular diseases, dyslipidaemia and kidney diseases was more common in previously diagnosed diabetes subjects than in others. Current alcohol drinking and smoking did not differ among the three FPG groups for men without diagnosed diabetes. Seafood consumption was very common in all participants.
Since the association of UA with plasma glucose was not altered when the analysis was stratified by either BMI or waist categories, we presented the data by adjustment for BMI. There was a slightly increasing trend in serum UA concentration when the levels of FPG or 2hPG increased from low to high, up to the FPG of 7.0mmol/l or the 2hPG of 10mmol/l; thereafter, the UA concentration started to decrease with a further increase in either the FPG or 2hPG levels (Figures 1(a) -(c) and 2(a)-(c) and Table 2 ). Multivariate adjustment for various potential confounders did not alter the UA-glucose association substantially although the regression coefficients have been reduced in some of the models as shown in Table 2 . Additional adjustment for seafood consumption, systolic (or diastolic) blood pressure, HDL-C, ApoB or ApoB-to-ApoA ratio, and menopause status did not change the observed associations either. There were only 10 men and 18 women reporting a history of taking diuretics for antihypertensive treatment. The serum UA levels were slightly higher in individuals who took diuretics than in those who did not (408 vs. 355 μmol/l for men and 307 vs. 280 μmol/l for women, p>0.05 for both). Fitting diuretic therapy into the models did not affect the associations of serum UA with plasma glucose. 
Discussion
In this population-based cross-sectional study, we found that serum UA concentration increased with increasing FPG levels up to the FPG level of 7.0 mmol/l, but notably decreased when FPG over 7.0 mmol/l. An increasing trend in the UA concentration at the 2hPG <10.0 mmol/l and a decreasing trend at 2hPG ≥10.0 mmol/l was also observed.
The results of the current study were similar to our previous findings among 1,288 men and 2,344 women aged 20-74 years old who were randomly recruited from three urban districts (Shinan, Shibei and Sifang) and 4 rural counties (Jiaonan, Pingdu, Chengyang and Laoshan) 4 years ago in the same city. 8 The improvement of the present study over the previous one is that many important confounding variables such as creatinine, C-reactive protein and fasting insulin were not available in the earlier study, but have been taken into account in the present study. Other cross-sectional studies have also shown that diabetic patients have the low levels in the UA levels; 2, 3, 10 the UA concentration was significantly elevated in people with IGT, 3 IFG and newly diagnosed diabetes in white populations. 7, 9 A study among Chinese in Taiwan 11 revealed that among non-diabetic subjects, FPG increased with increasing UA levels in women, but not in men. Our study further confirmed previous findings despite of the differences in assays used for the UA and in diagnostic criteria for diabetes in different studies. Very few studies have investigated the relationship between 2hPG and UA due to the fact that two-hour OGTTs have not been widely applied. A population-based cross-sectional study revealed that serum UA was strongly correlated with 2hPG in non-diabetic Mauritian men (r=0.15) and women (r=0.22) (p<0.001 for both). 12 We found in our previous study a weak UA-2hPG association. 8 In the current study the UA-2hPG association seems stronger in men than in women while the UA-FPG association stronger in women than in men. Since the cross-sectional studies were confounded by many concurrent conditions, the prospective implications of the UA levels in predicting diabetes need to be further investigated. Age, BMI, triglycerides, creatinine, C-reactive protein, blood pressure or treatment for hypertension, and alcohol intake for men, particularly, fasting insulin in higher ranges of plasma glucose distribution, is the important confounding factor for the association of serum UA with FPG and 2hPG. It probably reflected the biochemical interaction between glucose, insulin and purine metabolism, with increased excretions of UA during hyperglycaemia and glycosuria. 9, 13, 14 To the best of the authors' knowledge, only a few studies have investigated the relationship between fasting serum UA and type 2 diabetes incidence, and most of these studies were conducted in male population alone. 4, [15] [16] [17] [18] [19] Similar to these previous studies, recently, a population-based longitudinal study over a maximum 11 years of follow-up in Mauritius, 20 and another community-based prospective cohort study of 2,690 Chinese participants (age range, 35-97 years) over a median follow-up of 9.0 years in Chin-Shan town, Taiwan, 21 have found that high baseline UA levels predicted future type 2 diabetes development. The baseline serum UA level has also been found to independently predict the 2hPG levels during 13.5 years follow-up in a Swedish male population, with a low regression coefficient of 0.01 (p=0.026). 22 The strength of the current study includes: (1) the study population was randomly recruited, and did not include individuals who participated in our previous study in 2002;
(2) 75 g two-hour OGTTs have been conducted for all eligible participants to define diabetes status; (3) many potential confounding variables such as seafood consumption, serum creatinine, C-reactive protein, fasting insulin, ApoA, ApoB and diuretics medications were all available. However, urinary UA clearance and details on purine consumption were not available, and the number of people who took diuretics was low, limiting further exploration of the roles of these factors in the association between UA and different ranges of plasma glucose. Although the high seafood consumption may contribute to a higher prevalence of hyperuricemia in Qingdao compared with that previously reported in mainland China, 23 we were not able to reveal its statistical significance in the association between UA and plasma glucose in the current study.
In summary, fasting serum UA levels was higher in pre-diabetic population but lower in people with diabetes, suggesting that UA changes may serve as a marker of deterioration in glucose metabolism, but its clinical implication need to be further studied.
